23andMe (ME) Regains Nasdaq Compliance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. SKYD
6. HALO
7. BBIO
8. SPY
9. RCKT
10. CRWV

Go back to 23andMe (ME) Regains Nasdaq Compliance

23andMe Regains Compliance With Nasdaq Listing Requirements

October 30, 2024 5:00 PM EDT

SUNNYVALE, Calif., Oct. 30, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME) (the Company or 23andMe), a leading human genetics and preventive health company, today announced that the Company has regained compliance with the minimum closing bid price requirement under Nasdaq Listing Rule 5550(a)(2) and the majority independent board and various board committee requirements under Nasdaq Listing Rule 5605. Accordingly, the Company's Class A common stock will continue to be listed on The Nasdaq Capital Market and trade under the symbol ME.

About 23andMe
23andMe is a genetics-led consumer healthcare and biopharmaceutical company... More